Sr Staff Sub-Regional Marketing Business Partner - US1 - Northeast & South

New York, New York, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Bachelor’s degree in Life Sciences, Marketing, or a related field, with an advanced degree (MS, PhD) being preferred; an MBA is a plus. A minimum of 12 years of marketing experience in life sciences, genomics, or healthcare sectors is required, along with 6+ years of experience in people management or team/project leadership.

Responsibilities

The Sr Staff Sub-Regional Marketing Business Partner will formulate marketing plans to support Illumina’s commercial goals in the sub-region, develop go-to-market strategies, drive execution of those strategies, ensure marketing plans are relevant to the market and customers, develop a marketing tactics flight plan, assess customer pipeline KPIs, build target customer engagement plans, report on customer pipeline health KPIs, adjust plans to meet targets, and collaborate within a complex, matrixed organizational structure.

Skills

Marketing Strategy

Go-to-Market Strategy

Marketing Planning

Digital Marketing

Event Marketing

KPI Analysis

Customer Engagement

Business Alignment

Commercial Goals

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free